C lostridium diffi cile infections (CDIs) have increased in incidence and severity within the past decade in North America and Europe (1) , in large part because of the emergence of the hypervirulent North American pulsed-fi eld type 1 (NAP1/027/III) strains (2) (3) (4) (5) . Recently, interest has increased in the ribotype 078 strain. A 2007 North American study showed that ribotype 078 strains predominated in swine and cattle (83%-94% prevalence), but were rare in a group of hospitalized persons (4% prevalence) (6) . However, in studies from Europe and the United States, 078/V strains were found at a prevalence ranging from 3% to 11% (7) (8) (9) . In a subsequent study by the US group, analysis of the toxinotype V strains from humans and food animals showed that 83% of strains were either NAP7 or NAP8 (10) . A Dutch group has recently shown that 078/V strains increased from 3% to 13% during February [2005] [2006] [2007] [2008] and can be considered hypervirulent (11) . Our study aimed to determine the incidence rate of infections attributed to hypervirulent NAP7/078/V and NAP8/078/V strains of C. diffi cile in hospitals in Canada.
The Study
The An infection was considered healthcare-associated CDI if the patient's symptoms occurred at least 72 hours after hospital admission or if the symptoms resulted in readmission of a patient who had been hospitalized within the 2 months before the symptom onset date and who was not a resident in a long-term care facility or nursing home (12) . An infection was considered community-onset CDI if the healthcare-associated defi nition was not met. Outcomes 30 days postinfection were recorded to capture severe cases, which were defi ned as infections in patients admitted to an intensive care unit, in patients who had undergone colectomy, or in patients who had died (12) . Deaths were assessed by the Canadian Hospital Epidemiology Committee member and categorized into 3 groups: 1) death directly attributable to CDI, 2) death indirectly related to CDI by exacerbation of an existing disease condition, or 3) death not a result of CDI. The assessment was made from information obtained from medical charts, nurse logs, laboratory reports, and consultation with nursing and medical staff.
All stool specimens were cultured for C. diffi cile, and isolates were analyzed by PCR and pulsed-fi eld gel electrophoresis (PFGE) at the National Microbiology Laboratory. PFGE, ribotyping, and toxinotyping were performed as described (10, 11) . MICs were determined by agar dilution or Etest. The primers used for PCR and sequencing are listed in Table 1 . Macrorestriction patterns were analyzed with BioNumerics V4.5 (Applied Maths, Sint-Martens-Latem, Belgium). Fifteen NAP7 and 4 NAP8 patterns were identifi ed from isolates obtained from 2,794 patients (overall prevalence 0.68%). Table 2 Of the 19 patients identifi ed, 14 were men with an average age of 70.8 years (not including 1 pediatric case), and 4 were women with an average age of 52.2 years; the overall average age was 61.5 years (Table 2) . CDI was considered as community onset in 7 (37%) of 19 cases, and severe CDI was manifested in 3 (15.8%) case-patients (1 was healthcare-associated CDI and 2 were communityonset CDI). At 30 days postinfection for CDI, 26.3% of all patients had died, 1 death a direct result of CDI (5.3%), and 1 indirectly related; 10.6% of total deaths were attributable to CDI.
Sequence analysis of the tcdC gene showed that all strains carried a C184T transition that introduces a stop codon leading to a presumptive truncated protein of 61 residues, and a 39-bp deletion located downstream of the alternative stop codon. This tcdC variant has been previously described for toxinotype V strains (13 that were susceptible to moxifl oxacin (MIC <8 μg/mL) had identical gyrA and gyrB quinolone-resistance-determining regions (QRDR) sequences to the genes in C. diffi cile 630 (GenBank accession no. AM180355). Five moxifl oxacin-resistant isolates (MIC > 8 μg/mL) had no mutations in the gyrB QRDR but each had 1 mutation in the gyrA QRDR. One with MIC = 8 had an Asp71Val mutation; 3 with MIC = 16 and 1 with MIC >32 had a Thr82Ile mutation. These mutations have been previously described in moxifl oxacin-resistant C. diffi cile (14) .
Conclusions
C. diffi cile NAP7 and NAP8/078/V strains are relatively rare in hospitalized patients with CDI in Canada, in contrast to their prevalence in Europe and the United States (7-11). However, incidence rates have tripled from 0.5% in 2004 to 1.6% in 2008 (p = 0.22). There was a high association with a community onset, although dataset was too small to statistically confi rm that increased cases were more likely to be community onset; 2 (40%) of 5 deaths were attributable to CDI. Although the number of strains studied here was small, data are consistent with other studies that indicate a community association for NAP7 and NAP8/078/V strains (9-11). The prevalence of these strains in Canada may be higher than suggested here if they are a common cause of community-associated CDI, as studies have indicated (10, 11) . The role of animals in acquisition of NAP7 and NAP8/078/V strains was not evaluated because animal and food contact data were not available.
Molecular typing of C. diffi cile is typically performed by using ribotyping in Europe and PFGE/macrorestriction analysis in North America; both groups may use toxinotyping, which strictly looks at PaLoc variation. We showed a high correlation between NAP7, NAP8, ribotype 078, and toxinotype V strains by the 3 typing methods, which enabled results of separate studies to be compared. Furthermore, tcdC analysis provides an additional diagnostic tool for these strains because the gene has a 39-bp deletion and a C184T-transition in all isolates we studied.
Continued surveillance is warranted in humans, animals, and retail meat to determine whether NAP7 and 8/078/V strains will continue to emerge in patients hospitalized in Canada and to determine whether the sources of these infections are related to animals or food. Surveillance is especially important given that these strains appear to be hypervirulent as has been reported for NAP1/027/III strains (11) . Table 2 . C. diffi cile N07-00380 is a ribotype 078 control strain. C. diffi cile NAP7-CDC and NAP8-CDC control strains are toxinotype V. Isolates exhibiting high-level clindamycin resistance (>256 μg/mL) and harboring ermB are indicated. The amino acid change found in the gyrA protein is shown for the moxifl oxacin-resistant strain antimicrobial drug-resistance mechanisms.
representing NAP7 and NAP8 were kindly provided by B. Limbago (Centers for Disease Control and Prevention, Atlanta, GA, USA).
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